A busy morning of corporate news spans sectors from low-cost aviation to defence electronics, language services, and biotech, with Wizz Air (LSE:WIZZ) dominating the macro conversation after posting a near-wipeout of annual profit and declining to give full-year guidance, while Concurrent Technologies (LSE:CNC) landed its largest-ever contract win and Halma (LSE:HLMA) set out ambitious organic growth targets on the back of record results. Funding rounds, asset disposals, and clinical data updates round out a substantive pre-open agenda.
Wizz Air withholds full-year guidance amid geopolitical uncertainty
Wizz Air Holdings (LSE:WIZZ) reported a net profit of just €1.3 million for the full year, a near-total collapse in bottom-line earnings, as the low-cost carrier cited the weight of geopolitical uncertainty on its ability to forecast. The group expects significant capacity growth in the first half of its F27 financial year but said visibility beyond that point is too to commit to guidance.
Concurrent Technologies lands largest-ever £17 million defence contract
Concurrent Technologies secured a £17 million, four-year contract from a European defence prime, the largest single order in the company's history. Chief Executive Miles Adcock said the win demonstrated both the longevity of the group's product set and the strength of its long-standing customer relationships in the defence electronics space.
Halma targets low double-digit organic growth after record results
Halma (LSE:HLMA) set a target of low double-digit organic revenue growth for FY2027 following a year of record revenue and profit. The safety and environmental technology group said the photonics premium from its recent acquisition is expected to contribute around five percentage points to organic growth in the new financial year, providing a meaningful structural tailwind alongside its core operations.
RWS profit climbs 33% as AI sales and new operating model gain traction
RWS Holdings (AIM:RWS) reported a 33% increase in profit to £24 million, with Chief Executive Ben Faes attributing the improvement to the early positive effects of a new operating model and progress across three strategic growth pillars. Revenue and AI-related sales both gained momentum during the period, signalling that the group's repositioning around language and AI services is beginning to convert into financial results.
Foresight sells public markets arm to Guinness Global Investors
Foresight Group Holdings agreed to sell its public markets division, Foresight (LSE:FSG) Capital Management, to Guinness Global Investors. The transaction transfers approximately £1.0 billion of assets under management and 16 employees to Guinness, with FCM moving into discontinued operations on Foresight's books. The disposal represents a strategic narrowing of Foresight's focus toward its private markets and infrastructure businesses.
PayPoint maps profit growth path as four-unit restructure takes shape
PayPoint (LSE:PAY) set out expectations for profit growth in the current financial year as its restructure into four distinct business units progresses. The group flagged that profit will be more heavily weighted to the second half of the year, a phasing consideration investors will need to factor into near-term expectations.
Sirius Real Estate raises €185.1 million, takes two bonds to benchmark size
Sirius Real Estate (LSE:SRE) raised €185.1 million in a bond tap that brought two of its existing instruments to the €500 million benchmark size. Chief Financial Officer Chris Bowman said the group is maintaining its disciplined approach to leverage, framing the raise as a demonstration of market support and balance sheet flexibility rather than a shift in financial strategy.
Vivoryon pushes varoglutamstat toward Phase 2b as cash runway extends to Q4
Vivoryon Therapeutics said its current cash position will fund operations into the fourth quarter of 2026 as it advances varoglutamstat toward a Phase 2b trial in diabetic kidney disease. Chief Executive Frank Weber said the company has consistently demonstrated that the compound improves kidney function in elderly patients, particularly those with diabetes, underpinning the rationale for the next-stage trial investment.
Pri0r1ty secures £1.25 million Yorkville convertible loan and names new broker
Pri0r1ty Intelligence Group secured a £1.25 million convertible loan facility from Yorkville and appointed Bowsprit as its new broker. The group said the proceeds will support a push toward more than 500 platform users by the end of its financial year to September, the scaling of affiliate partnerships to reach thousands of consumers, and an expansion of compute capacity for its AI-driven intelligence offering.
BSF Enterprise secures £1 million interest-free convertible loan for tissue-engineering pipeline
BSF Enterprise (AIM:BSFA) obtained a £1 million interest-free convertible loan facility to provide additional working capital as it develops its tissue-engineered product portfolio. Chairman Geoff Baker said the facility adds financial flexibility at a stage when the group is actively building out its commercial opportunities across the portfolio.
Premier African secures funding to optimise Zulu lithium project
Premier African Minerals (AIM:PREM) obtained new funding to support optimisation and working capital at its Zulu lithium and tantalum project in Zimbabwe. The announcement followed the plant producing its first spodumene concentrate from a newly commissioned flotation circuit, marking a meaningful operational milestone for the project's development trajectory.
Jangada Mines flags 50,000-ounce upside at Paranaíta after drilling
Jangada Mines (AIM:JAN) reported drilling results at its Paranaíta gold project in Brazil that the company said point to potential upside of more than 50,000 ounces. Highlights from the programme included an intercept of 1.32 metres at 43.61 g/t gold and 11.20 metres at 0.83 g/t gold, with additional narrower high-grade intercepts reported across the TP2 section, supporting the case for a resource upgrade.
Poolbeg presents POLB 001 preclinical data on cytokine release syndrome
Poolbeg Pharma (AIM:POLB) presented preclinical data for its POLB 001 asset showing a reduction in cytokine release syndrome and a potential benefit in acute myeloid leukaemia. Principal Scientist Liam Tremble said the data reinforces the potential of POLB 001 to address one of the most significant challenges associated with cancer immunotherapy, with CRS representing a major tolerability barrier for existing treatments.
Strix Group appoints Andy Rainforth as chief executive
Strix Group appointed Andy Rainforth as its new Chief Executive Officer. Chair Gary Lamb said Rainforth's experience in driving growth, operational excellence, and value creation made him the right leader to guide the kettle controls and water technology group through its next phase of development.
M&C Saatchi reports early 2026 trading in line with expectations
M&C Saatchi (AIM:SAA) told shareholders at its annual general meeting that trading in the early part of 2026 is in line with expectations, with its Issues and Media divisions leading the recovery. The AIM-listed advertising group also disclosed a string of new client wins including UNICEF and Brand USA, adding momentum to its turnaround narrative heading into the second half of the year.
NCC Group ends strategic cyber review and exits City Code offer period
NCC Group (LSE:NCC) concluded its Cyber strategic review and confirmed it is no longer in an offer period under the City Code, bringing its Rule 8 disclosure obligations to an end. The conclusion of the review removes a significant overhang from the stock and clarifies the group's standalone strategic path for its cybersecurity operations.
Sequoia Economic Infrastructure posts 8.4% NAV total return for the year
Sequoia Economic Infrastructure Income Fund (LSE:SEQI) reported an 8.4% NAV total return for the year to 31 March. Director and CEO/CIO Randall Sandstrom described the result as another year of strong income generation and resilient credit performance across the portfolio, with the fund's infrastructure debt strategy continuing to deliver consistent returns for shareholders.
Serica completes $6.75 million acquisition of Catcher and Golden Eagle stakes
Serica Energy (AIM:SQZ) completed its acquisition from ONE-Dyas of a 10% interest in the Catcher field and a 5.21% interest in the Golden Eagle Area Development for a settled consideration of $6.75 million. The completion adds producing North Sea assets to Serica's portfolio and extends its operated and non-operated interests in the basin.
Amaroq commissions Phase 2 flotation circuit at Nalunaq, lifting gold recovery to 90-95%
Amaroq (AIM:AMRQ) commissioned its Phase 2 flotation circuit at the Nalunaq gold mine in Greenland, with the upgrade expected to lift gold recoveries from approximately 61% to 90-95% for the remainder of the year. Chief Executive Eldur Olafsson described the milestone as significant, with the step-change in recovery rates set to materially improve the economics of the operation going forward.
Safestore forecasts return to earnings growth but flags rate headwind on EPS
Safestore Holdings (LSE:SAFE) forecast a return to earnings growth while cautioning that higher interest rates will cap EPS expansion in the near term. The self-storage group reiterated its target of £30 million to £35 million of incremental EBITDA from non-like-for-like stores and its development pipeline on stabilisation, providing a medium-term earnings bridge for investors.
Serabi Gold files updated NI 43-101 reports for Palito and Coringa
Serabi Gold publicly filed updated NI 43-101 technical reports covering Mineral Reserve and Mineral Resource estimates for both its Palito Complex and Coringa Mine in Pará State, Brazil. The filings bring the group's resource disclosure into compliance with Canadian reporting standards and provide investors with a refreshed technical baseline for both assets.
